Business Context and Reporting Period
Aldeyra Therapeutics, Inc. filed a Form 8-K on July 28, 2026, reporting the entry into a material definitive agreement. The Company, incorporated in Delaware and trading on the Nasdaq under the symbol ALDX, executed a new lease for its corporate headquarters.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The financial data provided is limited to the terms of the new lease agreement:
- Monthly Base Rent: $12,201.00 (subject to annual increases).
- Security Deposit: $50,000.00.
- Additional Costs: Operating expenses, taxes, and other fees as defined in the lease.
Material Changes
The Company entered into a lease agreement with Bradford Street, L.L.C. for approximately 4,067 square feet of office space at 23 Bradford Street, Concord, Massachusetts. This represents a change in the Company's physical footprint and future fixed operating costs.
Outlook and Management Commentary
The lease term commences on September 1, 2026, and ends on September 30, 2029. Management intends to utilize the premises as its corporate headquarters. The filing notes that the lease contains customary representations and covenants regarding occupancy and maintenance. No specific guidance, risks, or contingencies beyond the standard lease obligations were disclosed in this report.
Investor Verification Points
- Verify the specific annual rent increase schedule detailed in the full text of the Office Lease (Exhibit 10.1).
- Confirm the total estimated annual cost including operating expenses and taxes.
- Review the Company's cash position to ensure it can support the $50,000 security deposit and ongoing rent obligations.